Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05370599 · ClinicalTrials.gov registry record · Phase 2
Hypertension in Young Adults Trial
A Phase 2 study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- Phase 2
- Development phase
- 36
- Enrollment target
NCT05370599: Clinical Trial Phase 2 study, sponsored by University of California, San Francisco.
NCT05370599 is a Phase 2 study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 36 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05370599, a Phase 2 study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 36 participants
- Enrollment target
Study Summary
This is a pilot randomized controlled trial which will test the effect of 3 different anti-hypertensive agents and 3 different strategies of engaging young adults in home blood pressure monitoring on blood pressure control, with secondary outcomes focused on quality of life and adverse events.
Primary Outcome
Systolic blood pressure will be collected using at home cuffed devices. The readings at end of the pilot trial (or most recent readings available) will be used for analysis of the primary outcome.
Interventions
- DRUG Anti-hypertensive agent: amlodipine
- DRUG Anti-hypertensive agent: Chlorthalidone
- DRUG Anti-hypertensive agent: Losartan
- DEVICE Home BP monitoring with cuffed device
- DEVICE Home BP monitoring with cuffed device + BP patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2022-04-15 |
| Est. Completion | 2026-01-07 |
| Phase | Phase 2 |
Why NCT05370599 stopped before completion
NCT05370599 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 5 interventions - of which Anti-hypertensive agent: amlodipine is the first listed.
NCT05370599 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05370599 about?
NCT05370599 is a clinical study titled "Hypertension in Young Adults Trial". This is a pilot randomized controlled trial which will test the effect of 3 different anti-hypertensive agents and 3 different strategies of engaging young adults in home blood pressure monitoring on blood pressure control, with secondary outcomes focused on quality of life and adverse events.
What is the current status of trial NCT05370599?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2022-04-15. Estimated completion is 2026-01-07.
What interventions are being tested in trial NCT05370599?
The interventions under investigation include: Anti-hypertensive agent: amlodipine (DRUG), Anti-hypertensive agent: Chlorthalidone (DRUG), Anti-hypertensive agent: Losartan (DRUG), Home BP monitoring with cuffed device (DEVICE), Home BP monitoring with cuffed device + BP patch (DEVICE).
Who is sponsoring clinical trial NCT05370599?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05370599's enrollment target sits among peer trials
36 1496th of 2000 higher than 477 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI